Anthim (Elusys Therapeutics, Inc.)
Welcome to the PulseAid listing for the Anthim drug offered from Elusys Therapeutics, Inc.. This Anthrax Protective Antigen-directed Antibody [EPC],Anthrax Protective Antigen-directed Antibody Interactions [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Elusys Therapeutics, Inc. |
| NON-PROPRIETARY NAME: | obiltoxaximab |
| SUBSTANCE NAME: | OBILTOXAXIMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthrax Protective Antigen-directed Antibody [EPC],Anthrax Protective Antigen-directed Antibody Interactions [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-03-18 |
| END MARKETING DATE: | 0000-00-00 |
Anthim HUMAN PRESCRIPTION DRUG Details:
| Item Description | Anthim from Elusys Therapeutics, Inc. |
| LABELER NAME: | Elusys Therapeutics, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 2016-03-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69604-204_6ff70900-99e5-11e6-bdf4-0800200c9a66 |
| PRODUCT NDC: | 69604-204 |
| APPLICATION NUMBER: | BLA125509 |
Other OBILTOXAXIMAB Pharmaceutical Manufacturers / Labelers:
